Bruker Expands Microbiology and Infection Diagnostics Portfolio
New updates include expanded capabilities for microbial identification and advancements in sepsis diagnostics and sequencing workflows.
New updates include expanded capabilities for microbial identification and advancements in sepsis diagnostics and sequencing workflows.
The FDA has granted Breakthrough Device Designation to Breath Diagnostics Inc.'s OneBreath, a breath-based test that assesses postoperative pneumonia risk in cardiac surgery patients using a single preoperative sample.
Finding themselves in a vicious tug-of-war, clinical labs are struggling to keep pace with emerging designer drugs.
The system combines enhanced sensitivity with automation to detect M-proteins at low concentrations, supporting early diagnosis of plasma cell disorders.
This collaboration aims to advance a smartphone-based hemoglobin test for accessible diagnostics of anemia and other health conditions.
The extraction-free library preparation technology is designed to deliver full transcriptome coverage for drug screening and toxicology studies.